Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DST Output was a prominent provider of integrated print and electronic customer communication solutions, specializing in high-volume transactional documents for the healthcare, financial services, and telecommunications sectors. The company played a vital role in the healthcare industry by managing the production and distribution of critical member communications, including Explanations of Benefits (EOBs), health plan statements, and regulatory notices. As a subsidiary of DST Systems, it was recognized as one of the largest First-Class mailers in the United States, utilizing advanced data-driven technologies to ensure accuracy and compliance. In 2016, Broadridge Financial Solutions acquired DST Output's North American operations for $410 million to enhance its investor and customer communication capabilities. Subsequently, in 2017, the company's UK operations were acquired by Paragon Group, leading to the rebranding of those services. Today, the legacy of DST Output continues through the integrated service offerings of its acquirers, supporting large-scale digital and physical engagement strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DST Output.